Comparison Study of Immunogenicity and Safety of SIBP’s Measles, Mumps and Rubella (MMR) Vaccine versus WHO prequalified GSK Measles, Mumps and Rubella (MMR) Vaccine

计划入组 1,200 人

Shanghai Meiji Health Science and Technology Co., Ltd

计划入组 95 人 · 首次发布于 2020 年 12 月 3 日

Study on Quality Traceability of Biological Products of Cordyceps Zhaqu and Treatment Effect of Insomnia

Mumps Vaccine, Live(Shanghai Institute of Biological Products Co., Ltd.)

peginterferon alfa-1b

Varicella vaccine, live attenuated(Shanghai Institute of Biological Products Co., Ltd.)

Lanzhou Institute Of Biological Products Co., Ltd.

China

Wuhan Institute of Biological Products Co., Ltd.

China

Shanghai Haohai Biological Technology Co.,Ltd

China

China's First Monkeypox Vaccine Enters Phase I Clinical Trials with Diverse Volunteer Cohort

BASF Launches New Fermentation Plant for Biological Crop Protection Products in Germany

Daiichi Sankyo Expands Global Research Network with New San Diego Institute and $154M Shanghai ADC Manufacturing Facility